Business Daily Media

Men's Weekly

.

HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment

HONG KONG SAR - Media OutReach Newswire - 6 December 2023 - A research team led by Hong Kong Baptist University (HKBU) has developed a novel drug delivery system for Alzheimer's disease (AD).

The researchers have engineered exosomes, extracellular vesicles released by cells, to effectively carry the bioactive compound Corynoxine-B extracted from the Chinese herbal medicine Gouteng to the brain of mice with AD. As Corynoxine-B can induce autophagy, a process that maintains the health of cells, this new drug delivery system using exosomes can improve cognitive function and movement while reducing the symptoms of AD.

The research findings have been published in the international academic journal Nature-Signal Transduction and Targeted Therapy.

Bioactive compound of Gouteng can treat AD

AD is the most common type of dementia in which the brain cells degenerate and die, characterised by a build-up of amyloid-beta and phospho-tau protein in the brain, resulting in the decline of the brain's cognitive functions. Currently more than 55 million people worldwide are dementia patients. In Hong Kong more than 100,000 elderly suffer from dementia and the number is anticipated to soar to more than 330,000 by 2039.

At present there is no curative treatment for AD. Available treatments can only delay the disease's progression and improve symptoms. HKBU's previous research projects found that Corynoxine-B, a bioactive compound of Gouteng, is effective in treating AD. However, the blood-brain barrier which protects the brain from potentially harmful substances in the bloodstream affects its uptake in brain.

Exosomes serve as drug carriers

To tackle this problem, a research team comprising Professor Li Min, Associate Dean (Teaching and Learning) of Chinese Medicine, and Dr Ashok Iyaswamy, Research Assistant Professor of the Teaching and Research Division at the School of Chinese Medicine at HKBU, along with other local, mainland and overseas scientists, have developed a novel approach to deliver Corynoxine-B to the brain using exosomes.

Exosomes are extracellular vesicles released by cells which can transport molecules between cells like nanocarriers. Recent studies have shown that they could be utilised as vehicles for drug delivery. To examine whether exosomes are effective drug carriers for AD, the researchers manipulated the neuronal cells in mice to overexpress an adaptor protein Fe65 on the surface of exosomes released by these cells. Fe65 is involved in the processing of amyloid-beta precursor protein (APP), which plays a crucial role in the development of AD.

By doing so, they observed more exosomes containing Fe65 were released by the neuronal cells. These engineered exosomes showed a good ability to migrate towards the neuronal cells with APP overexpressed in AD models. These findings suggest that the presence of Fe65 on the surface of exosomes enhanced their ability to specifically target and interact with the neuronal cells with elevated levels of APP, which is a characteristic feature of AD.

Reduction of accumulated amyloid-beta protein

Corynoxine-B is a natural inducer of autophagy which plays a crucial role in maintaining neuronal health. The research team loaded it into the engineered exosomes and injected it to the mice with AD to evaluate its potential as a therapeutic agent for the disease. Results show that engineered exosomes loaded with Corynoxine-B could enhance autophagy in mice, and were able to cross the blood-brain barrier to deliver Corynoxine-B to the brain, resulting in a 30% reduction of accumulated amyloid-beta protein.

In addition, various behavioural tests including the rotarod test, open field test, contextual fear conditioning test, and Morris's water maze test conducted on mice with AD showed that the application of engineered exosomes loaded with Corynoxine-B resulted in 25% recovery of the cognitive and locomotor behaviour.

Professor Li Min said: "Our study suggests that exosomes could be a promising new way to deliver drugs to the brain and treat AD. More research is needed, but this study provides hope that a cure for AD may be possible in the future. We hope that this research project will ultimately be beneficial to the elderly, individuals at high risk of neurodegeneration and neurodegenerative disease patients."

Hashtag: #Alzheimer'sdisease

The issuer is solely responsible for the content of this announcement.

News from Asia

Studio City Extends Toy Story Campaign with Splashing Summer Fun at Studio City Water Park

MACAU SAR - Media OutReach Newswire – 18 July 2025 - Studio City is excited to announce the extension of its popular Toy Story campaign, now making a big splash at Studio City Water Park...

Trend Micro Celebrates 20th Consecutive Recognition as a Leader in Gartner® Magic Quadrant™ Endpoint Protection Platforms

Threat intelligence and security capabilities continue to outpace threats HONG KONG SAR - Media OutReach Newswire - 18 July 2025 – Trend Micro Incorporated (TYO: 4704; TSE: 4704), a global cybers...

F88 earns Gold Level Certification for Client Protection

HANOI, VIETNAM - Media OutReach Newswire - 18 July 2025 - F88, a pioneer in Việt Nam's alternative finance sector, has once again affirmed its leadership position by being awarded the Gold Level C...

SKINARMA’s JAGER collection redefines street-smart carry with raw utility and urban edge

SINGAPORE - Media OutReach Newswire - 21 July 2025 - SKINARMA has launched the JAGER collection, a versatile lineup built for everyday explorers who need gear that keeps up with their pace...

Counterfeit and Refurbished Transducers Pose Serious Safety Risks

Merz Aesthetics® Hong Kong Launches Ultherapy® Authenticity Verification Reward Program This August Consumers Urged to Verify Ultherapy® Transducers Authenticity for Safe and Effective Treatments H...

IVD Medical Holding Limited (01931.HK): Officially launched the application for the US stablecoin license and accelerated the landing of the IVDNewCo Exchange ecosystem

HONG KONG SAR - Media OutReach Newswire - 21 July 2025 – IVD Medical Holding Limited(01931.HK) - Forward-looking layout of the historical opportunity of the US "Genius Act", the IVDD stablecoin pl...

FaatGo Officially Launches: A Hong Kong-Based Legal Platform Specializing in Criminal Defence and Injury Compensation

HONG KONG SAR - Media OutReach Newswire - 21 July 2025 - In response to the increasing demand for accessible and trustworthy legal information, FaatGo (https://faatgo.com/) has officially launche...

Galaxy Macau Ushers in ‘A Summer More Colorful’

The Award-Winning Integrated Resort Unveils a Dazzling Summer of Unparalleled Fun and Exclusive Rewards MACAU SAR - Media OutReach Newswire – 21 July 2025 - As the summer sun shines brightly, Gala...

Southeast Asia’s First Smart Battery Swapping Station Officially Launched: U Power Accelerates EV Ecosystem Across Three Continents

Hong Kong’s first station leads East Asia; Portugal and Peru mark U Power’s entry into Europe and South America PHUKET, THAILAND - EQS Newswire - 21 July 2025 - U Power Limited (Nasdaq: UCAR) and U...

V-Green introduces EV charging station partnership opportunities in the Philippines: Stable Revenue – Zero Risk – Breakthrough Potential

MANILA, PHILIPPINES - Media OutReach Newswire - 21 July 2025 - As Southeast Asia's electric vehicle (EV) market enters a phase of rapid expansion, V-Green Global Charging Station Development JSC a...

Baby boomers are driving development feasibility leading to larger apartments

As residential developers continue to grapple with feasibility issues on apartment projects, the sector is struggling to deliver volumes of new st...

Hays launches FY25/26 Salary Guide: ‘Salary Paradox’ deepens as pay rises fail Australians

Rising dissatisfaction with pay, progression and perks is fuelling a new wave of career change in FY25/26, as Australians demand more from employe...

Australian Businesses Still Stuck in the AI Hype Cycle

Data Governance Failures, ROI Gaps and Unclear Strategy Slowing Progress Despite artificial intelligence (AI) dominating headlines and boardroom ag...

How to ensure your manufacturing business survives international tariff turmoil

Optimising your operations in FY2026 will help you combat the challenges of a volatile trading environment. Up, down, in out…Since the commence...

Why Apptio is Enhancing Visibility into AI and Hybrid Cloud

AI investments have become a strategic priority for business with the mindset that if you're not using AI, you're falling behind. But according to...

Beyond borders: Building a scalable strategy for international hiring

For many Australian businesses, growth increasingly depends on thinking beyond local borders.  As wage pressures rise, and specialised talent pool...

Sell by LayBy